A Controlled Study of the Effectiveness of an Adaptive Closed-Loop Algorithm to Minimize Corticosteroid-Induced Stress Hyperglycemia in Type 1 Diabetes

To be effective in type 1 diabetes, algorithms must be able to limit hyperglycemic excursions resulting from medical and emotional stress. We tested an algorithm that estimates insulin sensitivity at regular intervals and continually adjusts gain factors of a fading memory proportional-derivative (FMPD) algorithm. In order to assess whether the algorithm could appropriately adapt and limit the degree of hyperglycemia, we administered oral hydrocortisone repeatedly to create insulin resistance. We compared this indirect adaptive proportional-derivative (APD) algorithm to the FMPD algorithm, which used fixed gain parameters. Each subject with type 1 diabetes (n = 14) was studied on two occasions, each for 33 h. The APD algorithm consistently identified a fall in insulin sensitivity after hydrocortisone. The gain factors and insulin infusion rates were appropriately increased, leading to satisfactory glycemic control after adaptation (premeal glucose on day 2, 148 ± 6 mg/dl). After sufficient time was allowed for adaptation, the late postprandial glucose increment was significantly lower than when measured shortly after the onset of the steroid effect. In addition, during the controlled comparison, glycemia was significantly lower with the APD algorithm than with the FMPD algorithm. No increase in hypoglycemic frequency was found in the APD-only arm. An afferent system of duplicate amperometric sensors demonstrated a high degree of accuracy; the mean absolute relative difference of the sensor used to control the algorithm was 9.6 ± 0.5%. We conclude that an adaptive algorithm that frequently estimates insulin sensitivity and adjusts gain factors is capable of minimizing corticosteroid-induced stress hyperglycemia.

[1]  W. Vach,et al.  Evidence-based insulin treatment in type 1 diabetes mellitus. , 2009, Diabetes research and clinical practice.

[2]  D. Greenhalgh Wound healing and diabetes mellitus. , 2003, Clinics in plastic surgery.

[3]  M. Falciglia Causes and consequences of hyperglycemia in critical illness , 2007, Current opinion in clinical nutrition and metabolic care.

[4]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[5]  M. Davidson,et al.  Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. , 1996, Metabolism: clinical and experimental.

[6]  A. El-Jabali Neural network modeling and control of type 1 diabetes mellitus , 2005, Bioprocess and biosystems engineering.

[7]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[8]  Andrey V. Savkin,et al.  Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients , 2005, IEEE Trans. Biomed. Eng..

[9]  Eyal Dassau,et al.  Proposed Clinical Application for Tuning Fuzzy Logic Controller of artificial Pancreas Utilizing a Personalization Factor , 2010, Journal of diabetes science and technology.

[10]  Thomas Desaive,et al.  Validation of a model-based virtual trials method for tight glycemic control in intensive care , 2010, Biomedical engineering online.

[11]  J. Geoffrey Chase,et al.  Impact of glucocorticoids on insulin resistance in the critically ill , 2011, Comput. Methods Programs Biomed..

[12]  E. Atlas,et al.  MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus Running Title: Closed-Loop System In Type 1 Diabetes , 2010 .

[13]  R. Femat,et al.  Theoretical blood glucose control in hyper- and hypoglycemic and exercise scenarios by means of an H(infinity) algorithm. , 2010, Journal of theoretical biology.

[14]  L. Magni,et al.  Model Predictive Control of Type 1 Diabetes: An in Silico Trial , 2007, Journal of diabetes science and technology.

[15]  Jessica R Castle,et al.  Continuous glucose monitoring in subjects with type 1 diabetes: improvement in accuracy by correcting for background current. , 2010, Diabetes technology & therapeutics.

[16]  Konstantina S. Nikita,et al.  An Insulin Infusion Advisory System Based on Autotuning Nonlinear Model-Predictive Control , 2011, IEEE Transactions on Biomedical Engineering.

[17]  Christopher E. Hann,et al.  Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model , 2005, Comput. Methods Programs Biomed..

[18]  Christopher E. Hann,et al.  In Silico Simulation of Long-Term Type 1 Diabetes Glycemic Control Treatment Outcomes , 2008, Journal of diabetes science and technology.

[19]  P. Schneiter,et al.  Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans. , 1998, American journal of physiology. Endocrinology and metabolism.

[20]  Janet M. Allen,et al.  Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies , 2011, BMJ : British Medical Journal.

[21]  G. Ward,et al.  Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients , 1997, Diabetologia.

[22]  W. Ward,et al.  Factors Influencing the Effectiveness of Glucagon for Preventing Hypoglycemia , 2010, Journal of diabetes science and technology.

[23]  L. King Impaired wound healing in patients with diabetes. , 2001, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[24]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[25]  S. Hadjadj,et al.  Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[26]  M. Saul,et al.  Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[27]  Roman Hovorka,et al.  Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. , 2010, Diabetes technology & therapeutics.

[28]  L. Mandarino,et al.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.

[29]  Steen Andreassen,et al.  A model of the endogenous glucose balance incorporating the characteristics of glucose transporters , 2000, Comput. Methods Programs Biomed..

[30]  Roman Hovorka,et al.  In Silico Testing—Impact on the Progress of the Closed Loop Insulin Infusion for Critically Ill Patients Project , 2008, Journal of diabetes science and technology.

[31]  W. Kenneth Ward,et al.  Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.

[32]  B. Walker,et al.  Glucocorticoids and insulin resistance: old hormones, new targets. , 1999, Clinical science.

[33]  Malgorzata E. Wilinska,et al.  Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin , 2005, IEEE Transactions on Biomedical Engineering.

[34]  E. Atlas,et al.  MD-Logic Artificial Pancreas System , 2010, Diabetes Care.

[35]  Christopher E. Hann,et al.  Development of a Clinical Type 1 Diabetes Metabolic System Model and in Silico Simulation Tool , 2008, Journal of diabetes science and technology.

[36]  C. Levetan Effect of hyperglycemia on stroke outcomes. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[37]  Eyal Dassau,et al.  In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. , 2009, Diabetes technology & therapeutics.

[38]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.